Cargando…

Antibodies to the High-Density Lipoprotein Receptor SR-B1 Potently Inhibit Hepatitis C Virus Replication In Vivo: New Avenues for Preventing Reinfection of the Liver Following Transplantation

Detalles Bibliográficos
Autor principal:	Drummer, Heidi E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232903/ https://www.ncbi.nlm.nih.gov/pubmed/24962233 http://dx.doi.org/10.1002/hep.27276

Ejemplares similares

The SR-BI Partner PDZK1 Facilitates Hepatitis C Virus Entry
por: Eyre, Nicholas S., et al.
Publicado: (2010)

High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
por: Sacks-Davis, Rachel, et al.
Publicado: (2013)

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation
por: Fafi-Kremer, Samira, et al.
Publicado: (2010)

Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies
por: Drummer, Heidi E.
Publicado: (2014)

Chronic hepatitis E after kidney transplantation with an antibody response suggestive of reinfection: a case report
por: Panning, Marcus, et al.
Publicado: (2019)

Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis
por: Chen, Yaqin, et al.
Publicado: (2015)

The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs
por: Vietheer, Patricia T., et al.
Publicado: (2017)

Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein
por: Itabe, Hiroyuki, et al.
Publicado: (2021)

The Role of Siglec-1 and SR-BI Interaction in the Phagocytosis of Oxidized Low Density Lipoprotein by Macrophages
por: Xiong, Yi-song, et al.
Publicado: (2013)

High density lipoprotein cholesterol and proteome in SR-B1 KO mice: lost in precipitation
por: Contreras-Duarte, Susana, et al.
Publicado: (2018)

High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotective Effects
por: Tran-Dinh, Alexy, et al.
Publicado: (2020)

Bosutinib high density lipoprotein nanoformulation has potent tumour radiosensitisation effects
por: Dehghankelishadi, Pouya, et al.
Publicado: (2023)

COVID-19 reinfection in the presence of neutralizing antibodies
por: Zhang, Ju, et al.
Publicado: (2021)

Circulating Oxidized Low-Density Lipoproteins and Antibodies against Oxidized Low-Density Lipoproteins as Potential Biomarkers of Colorectal Cancer
por: Diakowska, Dorota, et al.
Publicado: (2015)

Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy
por: Adachi, Keishi, et al.
Publicado: (2015)

Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin
por: Sasaki, Reina, et al.
Publicado: (2016)

Fasting Serum Low-Density Lipoprotein (LDL) Before Liver Transplantation Predicts Post-Transplant Survival
por: Li, Xiaojie, et al.
Publicado: (2019)

Biosynthesis of high density lipoprotein by chicken liver: nature of nascent intracellular high density lipoprotein
por: Banerjee, D, et al.
Publicado: (1983)

COVID-19 reinfection in a kidney transplant recipient
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

COVID-19 reinfection in a kidney transplant recipient
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases
por: Biazzo, Manuele, et al.
Publicado: (2022)

Anti-high-density lipoprotein antibodies and lipoprotein characteristics in systemic lupus erythematosus-related cardiovascular disease
por: Su, J, et al.
Publicado: (2005)

Artemisinin Analogues as Potent Inhibitors of In Vitro Hepatitis C Virus Replication
por: Obeid, Susan, et al.
Publicado: (2013)

Avenues of Death
Publicado: (1861)

Avenues of Death
Publicado: (1880)

Avenues of Death
Publicado: (1877)

N-acetylcysteine inhibits in vivo oxidation of native low-density lipoprotein
por: Cui, Yuqi, et al.
Publicado: (2015)

Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena
por: Chavda, Vivek P., et al.
Publicado: (2022)

Monoclonal antibody production and characterization for the measurement of plasma high density lipoprotein.
por: Lee, S. H., et al.
Publicado: (1996)

The association between oxidized low-density lipoprotein antibodies and hematological diseases
por: Li, Hao, et al.
Publicado: (2016)

Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome
por: Kim, Dal-Sik, et al.
Publicado: (2010)

COVID-19 reinfection: prolonged shedding or true reinfection?
por: Falahi, S., et al.
Publicado: (2020)

COVID‐19 reinfection or reactivation in a renal transplant patient
por: Abolghasemi, Sara, et al.
Publicado: (2021)

COVID-19 Reinfection in the Face of a Detectable Antibody Titer
por: Roy, Sayak
Publicado: (2021)

COVID-19 Reinfection in An Immunosuppressed Patient Without An Antibody Response
por: Hunsinger, Dr. Hillary P., et al.
Publicado: (2021)

SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer
por: Gutierrez-Pajares, Jorge L., et al.
Publicado: (2016)

Repopulating Decellularized Kidney Scaffolds: An Avenue for Ex Vivo Organ Generation
por: McKee, Robert A., et al.
Publicado: (2016)

Nasal Mucosa Exploited by SARS-CoV-2 for Replicating and Shedding during Reinfection
por: Li, Heng, et al.
Publicado: (2022)

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis
por: Yasunaka, Tetsuya, et al.
Publicado: (2011)

SR-BI associates with ABCG1 and inhibits ABCG1-mediated cholesterol efflux from cells to high-density lipoprotein 3
por: Song, Guohua, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4sqeii5e6eo19tc93ntobnrr6k